Results for "Understanding Pharmaceutical Distribution"
Transitioning COVID-19 Product Distribution to the Commercial Market
Throughout the COVID-19 pandemic, the federal government has primarily coordinated response efforts with the support of the private sector to develop, produce and distribute vaccines, personal protective equipment (PPE) and therapeutics. While this public health crisis continues, government and private-sector stakeholders are already thinking about the expected transition of COVID-19 product distribution to the commercial market — which could happen as early as the first quarter of this year.
HDA Statement on Proposed Tariffs of Pharmaceutical Products
HDA released a statement in response to President Donald J. Trump’s announcement on pledged tariffs for pharmaceuticals.
Amid Segment Growth, Specialty Distributors Achieve High-Service Efficiencies, Enhanced Reliability
New benchmarking data released by the HDA Research Foundation illustrate the continued value of HDA specialty distributors to the U.S. healthcare ecosystem.